US Map / Texas
State TX

Clinical Trials in Texas

Texas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Texas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 769 actively recruiting studies with Texas sites out of 769 registered in total. The busiest research areas in Texas are Breast Cancer, Advanced Solid Tumor, Endometrial Cancer. Leading sponsors running trials in the state include M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center, AstraZeneca. By stage, Texas trials break down as Phase 1 (192), Phase 2 (238), Phase 3 (155), Phase 4 (25).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
769
Recruiting Now
769
← Back to US Map
Top Conditions in Texas
Breast Cancer (23)Advanced Solid Tumor (18)Endometrial Cancer (15)Ovarian Cancer (13)Acute Myeloid Leukemia (13)Colorectal Cancer (12)Heart Failure (10)Solid Tumor (10)Prostate Cancer (9)Obesity (9)Cancer (8)Advanced Solid Tumors (7)

Frequently Asked Questions — Clinical Trials in Texas

How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 769 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 769. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Texas

NCT04604522 N/A
Recruiting
Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis...
Condition
Bronchiolitis Obliterans
Enrollment
15 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06350695 N/A
Recruiting
The ROle of Compression StocKings in Heart Failure Patients
Condition
Heart Failure,Congestive
Enrollment
50 pts
Location
United States
Sponsor
University of Maryland, Baltim
View Trial →
NCT06127407 Phase 3
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chon...
Condition
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Enrollment
136 pts
Location
United States, Australia, Belgium
Sponsor
Servier Bio-Innovation LLC
View Trial →
NCT06603844 Phase 1, Phase 2
Recruiting
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Condition
Solid Tumor
Enrollment
156 pts
Location
United States, United Kingdom
Sponsor
Corbus Pharmaceuticals Inc.
View Trial →
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT03981575 N/A
Recruiting
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Condition
Myotonic Dystrophy 1
Enrollment
700 pts
Location
United States, Canada, Germany
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT05698212 Phase 2
Recruiting
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometrio...
Condition
Endometriosis
Enrollment
75 pts
Location
United States
Sponsor
Hera Biotech, Inc.
View Trial →
NCT05828511 Phase 1, Phase 2
Recruiting
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerat...
Condition
Multiple Myeloma
Enrollment
149 pts
Location
United States, France, Spain
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07160244 Phase 3
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregn...
Condition
Healthy
Enrollment
6,000 pts
Location
United States, Argentina, Brazil
Sponsor
Pfizer
View Trial →
NCT06146257 Phase 1
Recruiting
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemi...
Condition
Acute Myeloid Leukemia
Enrollment
48 pts
Location
United States
Sponsor
GluBio Therapeutics Inc.
View Trial →
NCT06947928 Phase 2, Phase 3
Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint In...
Condition
Advanced Or Metastatic Merkel Cell Carcinoma
Enrollment
118 pts
Location
United States
Sponsor
TuHURA Biosciences, Inc.
View Trial →
NCT06906107 N/A
Recruiting
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for N...
Condition
Neck Pain Musculoskeletal
Enrollment
160 pts
Location
United States
Sponsor
Baylor University
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06207799 Phase 2
Recruiting
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With E...
Condition
Multiple Myeloma
Enrollment
40 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07579182 Phase 1
Recruiting
Hormones, Outcomes, and Pain Pathways in Exercise Study
Condition
Breast Pain
Enrollment
140 pts
Location
United States
Sponsor
University of Houston
View Trial →
NCT06980428 Phase 1
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynam...
Condition
Healthy Participants
Enrollment
136 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT07165028 Phase 3
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment
4,500 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
View Trial →
NCT04408430 N/A
Recruiting
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Condition
Mitral Annular Calcification
Enrollment
210 pts
Location
United States, Mexico
Sponsor
Mayra Guerrero
View Trial →
NCT06576271 Phase 1
Recruiting
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE...
Condition
Systemic Lupus Erythematosus
Enrollment
142 pts
Location
United States, Argentina, Brazil
Sponsor
GlaxoSmithKline
View Trial →
NCT06508801 N/A
Recruiting
Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
Condition
Parkinson's Disease and Parkinsonism
Enrollment
20 pts
Location
United States
Sponsor
The University of Texas Health
View Trial →
NCT04469530 Phase 2
Recruiting
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk...
Condition
Solid Tumor
Enrollment
55 pts
Location
United States
Sponsor
Emory University
View Trial →
NCT04949464 N/A
Recruiting
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoki...
Condition
HIV Infection
Enrollment
100 pts
Location
United States
Sponsor
AIDS Malignancy Consortium
View Trial →
NCT06576037 Phase 1
Recruiting
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembroliz...
Condition
Solid Tumor
Enrollment
128 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
Page 3 of 31 — 769 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology